Raintree Systems (“Raintree”), a leading provider of electronic health record (EHR) and revenue cycle management (RCM) software solutions to the therapy market, announced it received a significant investment from Serent Capital, a growth-focused firm that invests in technology companies. The investment will allow Raintree to continue innovating and building its market leading therapy software platform.
Founded more than 36 years ago by Richard and Lorraine Welty, Raintree has evolved into the preeminent provider of EHR and practice management solutions to therapy and rehabilitation clinics. The company’s practice management platform allows therapists to manage therapy clinics more efficiently by improving workflow productivity. The platform automates manual processes and offers intuitive analytics and simplified reporting for clinicians to ease staff’s workload and optimize business operations. The company’s solutions are used by hundreds of customers nationally.
“Since our founding our passion has been delivering superior software solutions, and building a great company to serve our customers. We’re thrilled to work hand-in-hand with Serent and their team to provide valuable software and relationship-first customer service to more customers,” stated Lorraine Welty, Co-Founder of Raintree Systems.
Kevin Frick, Partner at Serent Capital added, “Raintree is the preeminent platform for enterprise and mid-sized therapy providers. The team has done a fantastic job of creating a robust, feature-rich product. Their passion for both their customers and their product showed up clearly in the overwhelmingly positive feedback we received from customers. We look forward to partnering with them as they enter the next chapter of growth.”
Raintree provides one of the most complete and comprehensive therapy & rehabilitation software platforms in the industry and empowers therapists and operators that desire to grow their business. Through their approach to creating improvements in operational efficiency and increased productivity, they have become the preferred value creator for 6 out of the 10 largest physical therapy (PT) groups in the country.
Serent is an active investor in the healthcare market, having invested in over 20 healthcare technology companies in the last 10 years. Recent investments include EDH, Procurement Partners, and Hybrent. To learn more about Serent’s partnership with healthcare companies visit: https://serentcapital.com/healthcare/.
Disclaimer:
This publication is for informational purposes only, and nothing contained herein constitutes an offer to sell or a solicitation of an offer to buy any interest in any investment vehicle managed by Serent Capital or any company in which Serent Capital or its affiliates have invested. An offer or solicitation will be made only through a final private placement memorandum, subscription agreement and other related documents with respect to a particular investment opportunity and will be subject to the terms and conditions contained in such documents, including the qualifications necessary to become an investor. Serent Capital does not utilize its website to provide investment or other advice, and nothing contained herein constitutes a comprehensive or complete statement of the matters discussed or the law relating thereto. Information provided reflects Serent Capital’s views as of a particular time and are subject to change without notice. You should obtain relevant and specific professional advice before making any investment decision.
Executive endorsements of Serent Capital are for illustrative purposes, designed to attract business development contacts, and should not be construed as a client or investor testimonial of Serent Capital's investment advisory services. All such endorsements are from current or former portfolio company leadership about Serent Capital’s ability to provide services to their companies. Certain executives are also investors in Serent Capital’s investment vehicle(s), and as such, there is an inherent conflict in that those executives have an incentive to provide favorable reviews of Serent Capital’s business practices for the benefit of the investment vehicles that they hold a personal ownership interest in. Serent Capital has not, directly or indirectly, paid any compensation to such individuals for their endorsements.
Certain information on this Website may contain forward-looking statements, which are subject to risks and uncertainties and speak only as of the date on which they are made. The words “believe”, “expect”, “anticipate”, “optimistic”, “intend”, “aim”, “will” or similar expressions are intended to identify forward-looking statements. Serent Capital undertakes no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future developments or otherwise. Past performance is not indicative of future results; no representation is being made that any investment or transaction will or is likely to achieve profits or losses similar to those achieved in the past, or that significant losses will be avoided.
